Overview
Epitalon (also known as Epithalon or Epithalone) is a synthetic tetrapeptide derived from epithalamine, a natural peptide preparation from the pineal gland. It was developed at the St. Petersburg Institute of Bioregulation and Gerontology and appears mainly in research on ageing and longevity.
One distinction governs how the literature should be read. Epitalon is not the same as epithalamine. Some of the published studies on 'Epitalon' in fact examined the original preparation, and which compound a study used determines how its results should be interpreted.
In research the compound is most often linked to cellular ageing and to hypotheses around telomerase. Preclinical and historical research interest is real. Controlled human studies do exist, but are confined to older cohorts: predominantly Russian and Ukrainian, published between 1999 and 2012, with dozens of participants and largely from a single research line. Modern, independent randomised studies are absent. Public attention in longevity communities is large relative to the maturity of that evidence. That ratio calls for careful interpretation.
Mechanism of action
In cellular-ageing research, Epitalon appears mainly because of its hypothesised interaction with telomerase. Telomerase is the enzyme that maintains telomere length during cell division. The compound may also modulate melatonin production through interaction with the pineal gland.
Telomerase-related hypotheses
- Proposed activation of telomerase in somatic cell models
- Hypothesised influence on the maintenance of telomere length during cell division
- Telomerase narratives are often attached to Epitalon but require careful weighing of source quality
Neuro-endocrine signalling
- Modulation of melatonin secretion, reported in animal models
- Interaction with pineal gland function and circadian signalling
- Connection to broader hypotheses on neuro-endocrine ageing
Interpretive caution
- Much of the cited literature is older and selectively quoted in public discussions
- Mechanistic hypotheses are often extended further than the experimental data support
- A hypothesis about the mechanism is not an established biological conclusion
Research findings
- Telomerase activation observed in human somatic cell cultures
- Telomere length extension in cell-culture models
- Modulation of melatonin secretion patterns in animal models
- Lifespan extension reported in rodent studies
- Changes in antioxidant gene expression in an ageing tissue model
Cellular ageing models
- Telomerase activation observed in human somatic cell cultures
- Telomere length extension in cell-culture models
- Telomerase activation and telomere extension in human cell lines recently also reported by an independent group outside the original research tradition (Al-Dulaimi et al., 2025, Brunel University London). This strengthens the hypothesis at the cellular level but does not yet confirm it at the organism level.
Neuro-endocrine and circadian models
- Modulation of melatonin secretion patterns in animal models
- Changes in antioxidant gene expression in an ageing tissue model
Longevity-associated observations
- Lifespan extension reported in rodent studies under specific experimental conditions. These findings come primarily from a single research tradition and have not yet been independently replicated outside it.
Research context
Most Epitalon research has been conducted in Russian gerontological institutions. Controlled human studies do exist, but are confined to older cohorts: predominantly Russian and Ukrainian, published between 1999 and 2012, with dozens of participants and largely from a single research line. Modern, independent randomised studies are absent. Recent in-vitro work by an independent group (Brunel University London, UK, 2025) has begun to re-test the core claims at the cellular level. Modern human confirmation of those cellular findings remains absent for now.
The compound continues to draw attention in longevity discussions because of its conceptual link to telomere biology. Scientific confidence nonetheless remains conservative, given the distance between what has been published and what is claimed publicly.
Open questions
Epitalon remains conceptually interesting. The gap between public claims and published evidence quality makes careful interpretation more important here than for many other compounds.
- Modern, independent randomised human studies are absent; the available controlled human data come from older cohorts (1999-2012, largely one research line)
- The translation of cell-culture observations to organism-level outcomes is poorly characterised
- The mechanism of telomerase activation is not fully described within modern frameworks
- Bioavailability and pharmacokinetic profile are incompletely mapped
- Long-term effects on telomere dynamics in vivo are unclear
- Source quality in public discourse is uneven, and anti-ageing narratives regularly oversimplify the science
Research outlook
Modern controlled human studies on telomerase activation with standardised endpoints, a natural fit for clinical research groups working on biomarkers of biological ageing.
Independent replication of the historical findings in Western clinical settings, work that any well-equipped cell-biology department could carry out on a modest scale.
Research into the neuro-endocrine and circadian effects with contemporary methodology, relevant for groups in chronobiology and neuro-endocrinology.
Integration with broader ageing and longevity frameworks under rigorous conditions, meaningful for centres at the intersection of cellular and systemic ageing.
Critical reappraisal of the older literature against current evidence standards, a contribution review-focused researchers can make without new experimental work.
Scientific interest
One of the few peptides discussed in direct relation to hypotheses on telomerase activation in somatic cells.
Connection to pineal gland biology, melatonin regulation, and neuro-endocrine ageing.
Intersection of gerontology and cellular ageing biology: conceptually relevant but evidence-limited.
The high public interest relative to evidence maturity shows how much careful scientific interpretation matters here.
Specifications
| Sequence | Ala-Glu-Asp-Gly |
|---|---|
| Molecular formula | C14H22N4O9 |
| Molecular weight | 390.35 Da |
| CAS | 307297-39-8 |
| Research phase | Emerging human research |
References
- Epithalon decelerates aging and suppresses development of breast adenocarcinomas in transgenic her-2/neu mice · Anisimov VN, Khavinson VKh, et al. · Bull Exp Biol Med · 2002
- Peptides and Ageing · Khavinson VKh · Neuro Endocrinol Lett · 2002
- Aging of the pineal gland · Khavinson VKh, Golubev AG · Adv Gerontol · 2002
- Effect of the synthetic pineal peptide epitalon on spontaneous carcinogenesis in female C3H/He mice · Kossoy G, Anisimov VN, et al. · In Vivo · 2006
- The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy · Gatta M, Dovizio M, Milillo C, et al. · Stem Cell Rev Rep · 2025
- Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity · Al-Dulaimi S, Thomas R, Matta S, Roberts T. · Biogerontology · 2025
- Overview of Epitalon — Highly Bioactive Pineal Tetrapeptide with Promising Properties · Araj SK, Brzezik J, Mądra-Gackowska K, Szeleszczuk Ł · Int J Mol Sci · 2025
Availability
In stock · Batch PEP-EPI-2026-01 · HPLC 99.11 % · released 2 Jun 2026